## Correct Answer: D. B and C The placental barrier is selectively permeable, and molecular size is the primary determinant of transplacental passage. **Albumin** (MW ~66 kDa) and **Immunoglobulin M** (MW ~900 kDa) are large proteins that cannot cross the placenta due to their size exceeding the effective pore size of the placental syncytiotrophoblast. In contrast, **Iron** crosses via specific placental iron transporters (DMT1, IREG1) in a saturable, active transport mechanism—critical for fetal hemoglobin synthesis and preventing anemia in Indian populations with high prevalence of iron deficiency. **Immunoglobulin G** (MW ~150 kDa), though larger than albumin, possesses a specialized Fc receptor (FcRn) on trophoblastic cells that mediates receptor-mediated endocytosis, allowing transplacental passage. This IgG transfer provides passive immunity to the newborn for the first 3–6 months—a key protective mechanism in countries with high infectious disease burden. The discriminating principle: size alone does not determine passage; active transport mechanisms and receptor-mediated pathways override simple diffusion barriers. IgM cannot cross because it lacks the Fc receptor binding domain and is too large for paracellular transport, making it a marker of congenital infection (e.g., congenital toxoplasmosis, rubella) when detected in cord blood. ## Why the other options are wrong **A. A and B** — This is wrong because iron **does cross** the placenta via active transport mechanisms (DMT1 and IREG1 transporters). While albumin cannot cross, iron's ability to cross is essential for fetal erythropoiesis and is a high-yield concept in obstetrics. The trap assumes students will group all large molecules together, missing the active transport exception. **B. C and D** — This is wrong because **IgG crosses the placenta** via FcRn-mediated receptor endocytosis, providing crucial passive immunity to the newborn. Only IgM cannot cross. Students who rely solely on molecular weight (IgG ~150 kDa vs IgM ~900 kDa) without knowing the FcRn mechanism fall into this trap, missing the immunological significance of IgG transfer in Indian neonates. **C. Only C** — This is wrong because it omits **albumin**, which is a large protein (66 kDa) that cannot cross the placenta. While IgM is correctly identified as unable to cross, the answer is incomplete. This trap targets students who focus only on immunoglobulins and forget that other large proteins (albumin, fibrinogen) are also blocked by the placental barrier. ## High-Yield Facts - **Albumin** (66 kDa) cannot cross the placenta; its presence in cord blood indicates placental damage or fetal liver disease. - **IgG** crosses via **FcRn receptor**-mediated endocytosis; provides passive immunity for 3–6 months postnatally. - **IgM** cannot cross the placenta; its presence in cord blood is diagnostic of congenital infection (TORCH, syphilis). - **Iron** crosses via active transport (DMT1, IREG1); critical for preventing fetal anemia in iron-deficient mothers. - Placental permeability depends on: molecular size, charge, lipid solubility, and presence of specific transporters/receptors—not size alone. ## Mnemonics **LARGE PROTEINS BLOCKED** **A**lbumin, **I**gM = cannot cross (>60 kDa, no receptor). **I**gG = crosses (FcRn receptor). **I**ron = crosses (active transport). Remember: Size + Receptor = Passage. **Cord Blood IgM = Infection** If IgM detected in cord blood → congenital infection (TORCH, syphilis). IgM cannot cross placenta, so fetal production = infection. Use this to recall IgM is blocked. ## NBE Trap NBE pairs "large molecules" (albumin, IgM, IgG) expecting students to group them by size alone, missing that IgG has a specialized FcRn receptor that overrides the size barrier. The trap also assumes students will forget that iron, despite being small, requires active transport—making it seem like all small molecules cross passively. ## Clinical Pearl In Indian obstetric practice, detecting **IgM in cord blood** is a red flag for congenital infections (toxoplasmosis, rubella, syphilis)—a critical screening point in high-prevalence regions. Conversely, **maternal IgG transfer** is why exclusively breastfed infants in India have lower infection rates in the first 3–6 months, making this concept clinically actionable at the bedside. _Reference: DC Dutta's Textbook of Obstetrics Ch. 6 (Placenta); Harrison Ch. 297 (Pregnancy); Robbins Ch. 10 (Placental Pathology)_
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.